메뉴 건너뛰기




Volumn 110, Issue 6, 2012, Pages 870-876

Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

EID: 84865527834     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.05.014     Document Type: Article
Times cited : (228)

References (30)
  • 2
    • 61549090009 scopus 로고    scopus 로고
    • Heart failure with normal left ventricular ejection fraction
    • M.T. Maeder, D.M. Kaye Heart failure with normal left ventricular ejection fraction J Am Coll Cardiol 53 2009 905 918
    • (2009) J Am Coll Cardiol , vol.53 , pp. 905-918
    • Maeder, M.T.1    Kaye, D.M.2
  • 8
    • 32644436929 scopus 로고    scopus 로고
    • B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure
    • Y. Iwanaga, I. Nishi, S. Furuichi, T. Noguchi, K. Sase, Y. Kihara, Y. Goto, H. Nonogi B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure J Am Coll Cardiol 47 2006 742 748
    • (2006) J Am Coll Cardiol , vol.47 , pp. 742-748
    • Iwanaga, Y.1    Nishi, I.2    Furuichi, S.3    Noguchi, T.4    Sase, K.5    Kihara, Y.6    Goto, Y.7    Nonogi, H.8
  • 10
    • 29344457181 scopus 로고    scopus 로고
    • B-type natriuretic peptide levels in obese patients with advanced heart failure
    • T.B. Horwich, M.A. Hamilton, G.C. Fonarow B-type natriuretic peptide levels in obese patients with advanced heart failure J Am Coll Cardiol 47 2006 85 90
    • (2006) J Am Coll Cardiol , vol.47 , pp. 85-90
    • Horwich, T.B.1    Hamilton, M.A.2    Fonarow, G.C.3
  • 14
    • 29244432482 scopus 로고    scopus 로고
    • Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
    • American Society of Echocardiography Guidelines and Standards Committee, European Association of Echocardiography C.Q.W
    • R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S.J. Sutton, W.J. Stewart, C.Q.W. Group American Society of Echocardiography Guidelines and Standards Committee, European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
    • (2005) J Am Soc Echocardiogr , vol.18 , pp. 1440-1463
    • Lang, R.M.1    Bierig, M.2    Devereux, R.B.3    Flachskampf, F.A.4    Foster, E.5    Pellikka, P.A.6    Picard, M.H.7    Roman, M.J.8    Seward, J.9    Shanewise, J.S.10    Solomon, S.D.11    Spencer, K.T.12    Sutton, M.S.J.13    Stewart, W.J.14
  • 17
    • 77956324154 scopus 로고    scopus 로고
    • Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction
    • M.T. Maeder, B.R. Thompson, H.P. Brunner-La Rocca, D.M. Kaye Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction J Am Coll Cardiol 56 2010 855 863
    • (2010) J Am Coll Cardiol , vol.56 , pp. 855-863
    • Maeder, M.T.1    Thompson, B.R.2    Brunner-La Rocca, H.P.3    Kaye, D.M.4
  • 18
    • 84856403426 scopus 로고    scopus 로고
    • Can brain natriuretic Peptide be used to guide the management of patients with heart failure and a preserved ejection fraction?: The wrong way to identify new treatments for a nonexistent disease
    • M. Packer Can brain natriuretic Peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease Circ Heart Fail 4 2011 538 540
    • (2011) Circ Heart Fail , vol.4 , pp. 538-540
    • Packer, M.1
  • 24
    • 0029741452 scopus 로고    scopus 로고
    • Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases
    • T. Ando, K. Ogawa, K. Yamaki, M. Hara, K. Takagi Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases Chest 110 1996 462 468
    • (1996) Chest , vol.110 , pp. 462-468
    • Ando, T.1    Ogawa, K.2    Yamaki, K.3    Hara, M.4    Takagi, K.5
  • 26
    • 47849087223 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: Treat now by treating comorbidities
    • S.J. Shah, M. Gheorghiade Heart failure with preserved ejection fraction: treat now by treating comorbidities JAMA 300 2008 431 433
    • (2008) JAMA , vol.300 , pp. 431-433
    • Shah, S.J.1    Gheorghiade, M.2
  • 27
    • 84857857236 scopus 로고    scopus 로고
    • Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction
    • S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, A.A. Zachariah, X.H. Wehrens, A. Deswal Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
    • (2012) J Am Coll Cardiol , vol.59 , pp. 998-1005
    • Ather, S.1    Chan, W.2    Bozkurt, B.3    Aguilar, D.4    Ramasubbu, K.5    Zachariah, A.A.6    Wehrens, X.H.7    Deswal, A.8
  • 28
    • 82555200331 scopus 로고    scopus 로고
    • Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial
    • I.S. Anand, T.S. Rector, J.G. Cleland, M. Kuskowski, R.S. McKelvie, H. Persson, J.J. McMurray, M.R. Zile, M. Komajda, B.M. Massie, P.E. Carson Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial Circ Heart Fail 4 2011 569 577
    • (2011) Circ Heart Fail , vol.4 , pp. 569-577
    • Anand, I.S.1    Rector, T.S.2    Cleland, J.G.3    Kuskowski, M.4    McKelvie, R.S.5    Persson, H.6    McMurray, J.J.7    Zile, M.R.8    Komajda, M.9    Massie, B.M.10    Carson, P.E.11
  • 29
    • 0035846616 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America
    • S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldman, G.S. Francis, T.G. Ganiats, S. Goldstein, G. Gregoratos, M.L. Jessup, R.J. Noble, M. Packer, M.A. Silver, L.W. Stevenson, R.J. Gibbons, E.M. Antman, J.S. Alpert, D.P. Faxon, V. Fuster, A.K. Jacobs, L.F. Hiratzka, R.O. Russell, S.C. Smith Jr ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America Circulation 104 2001 2996 3007
    • (2001) Circulation , vol.104 , pp. 2996-3007
    • Hunt, S.A.1    Baker, D.W.2    Chin, M.H.3    Cinquegrani, M.P.4    Feldman, A.M.5    Francis, G.S.6    Ganiats, T.G.7    Goldstein, S.8    Gregoratos, G.9    Jessup, M.L.10    Noble, R.J.11    Packer, M.12    Silver, M.A.13    Stevenson, L.W.14    Gibbons, R.J.15    Antman, E.M.16    Alpert, J.S.17    Faxon, D.P.18    Fuster, V.19    Jacobs, A.K.20    more..
  • 30
    • 79960430593 scopus 로고    scopus 로고
    • Ranolazine for the treatment of heart failure with preserved ejection fraction: Background, aims, and design of the RALI-DHF study
    • C. Jacobshagen, L. Belardinelli, G. Hasenfuss, L.S. Maier Ranolazine for the treatment of heart failure with preserved ejection fraction: background, aims, and design of the RALI-DHF study Clin Cardiol 34 2011 426 432
    • (2011) Clin Cardiol , vol.34 , pp. 426-432
    • Jacobshagen, C.1    Belardinelli, L.2    Hasenfuss, G.3    Maier, L.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.